Literature DB >> 30457357

Transport and delivery of interferon-α through epithelial tight junctions via pH-responsive poly(methacrylic acid-grafted-ethylene glycol) nanoparticles.

Mary Caldorera-Moore1, Julia E Vela Ramirez2,3,4, Nicholas A Peppas2,3,4,5,6,7.   

Abstract

Whereas significant advancements have been made in our fundamental understanding of cancer, they have not yet translated into effective clinical cancer treatments. One of the areas that has the potential to improve the efficacy of cancer therapies is the development of novel drug delivery technologies. In particular, the design of pH-sensitive polymeric complexation hydrogels may allow for targeted oral delivery of a wide variety of chemotherapeutic drugs and proteins. In this work, poly(methacrylic acid-grafted-ethylene glycol) hydrogel nanoparticles were synthesised, characterised, and studied as matrix-type, diffusion-controlled, pH-responsive carriers to enable the oral delivery of the chemotherapeutic agent interferon alpha (IFN-α). The biophysical mechanisms controlling the transport of IFN-α were investigated using a Caco-2/HT29-MTX co-culture as a gastrointestinal (GI) tract model. The synthesised nanoparticles exhibited pH-responsive swelling behaviour and allowed the permeation of IFN-α through the tight junctions of the developed cellular GI epithelium model. These studies demonstrate the capabilities of these particles to contribute to the improved oral delivery of protein chemotherapeutics.

Entities:  

Keywords:  Caco-2 cell lines; GI tract delivery systems; Responsive hydrogels; interferon alpha (IFN-α); pH-sensitive hydrogel nanoparticles

Mesh:

Substances:

Year:  2019        PMID: 30457357      PMCID: PMC6522304          DOI: 10.1080/1061186X.2018.1547732

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  53 in total

Review 1.  Interferon-alpha as an immunotherapeutic protein.

Authors:  Diana L Brassard; Michael J Grace; Ronald W Bordens
Journal:  J Leukoc Biol       Date:  2002-04       Impact factor: 4.962

2.  Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha.

Authors:  Alejandro Sánchez; María Tobío; Libia González; Angels Fabra; María J Alonso
Journal:  Eur J Pharm Sci       Date:  2003-03       Impact factor: 4.384

Review 3.  Principles of transmucosal delivery of therapeutic agents.

Authors:  James Blanchette; Nikhil Kavimandan; Nicholas A Peppas
Journal:  Biomed Pharmacother       Date:  2004-04       Impact factor: 6.529

Review 4.  Interferon-alpha in tumor immunity and immunotherapy.

Authors:  Filippo Belardelli; Maria Ferrantini; Enrico Proietti; John M Kirkwood
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

5.  HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer.

Authors:  C Pontier; J Pachot; R Botham; B Lenfant; P Arnaud
Journal:  J Pharm Sci       Date:  2001-10       Impact factor: 3.534

6.  Oral delivery of insulin using pH-responsive complexation gels.

Authors:  A M Lowman; M Morishita; M Kajita; T Nagai; N A Peppas
Journal:  J Pharm Sci       Date:  1999-09       Impact factor: 3.534

7.  Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models.

Authors:  C Meaney; C O'Driscoll
Journal:  Eur J Pharm Sci       Date:  1999-07       Impact factor: 4.384

8.  Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.

Authors:  Robert J Motzer; Jennifer Bacik; Barbara A Murphy; Paul Russo; Madhu Mazumdar
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

Review 9.  Interferons: mechanisms of action and clinical applications.

Authors:  Simrit Parmar; Leonidas C Platanias
Journal:  Curr Opin Oncol       Date:  2003-11       Impact factor: 3.645

10.  Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?

Authors:  Isabel Behrens; Thomas Kissel
Journal:  Eur J Pharm Sci       Date:  2003-08       Impact factor: 4.384

View more
  4 in total

Review 1.  Emerging Fabrication Strategies of Hydrogels and Its Applications.

Authors:  Fayaz Ali; Imran Khan; Jianmin Chen; Kalsoom Akhtar; Esraa M Bakhsh; Sher Bahadar Khan
Journal:  Gels       Date:  2022-03-24

Review 2.  Engineering precision nanoparticles for drug delivery.

Authors:  Michael J Mitchell; Margaret M Billingsley; Rebecca M Haley; Marissa E Wechsler; Nicholas A Peppas; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2020-12-04       Impact factor: 84.694

Review 3.  Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic.

Authors:  Vladimir A Ljubimov; Arshia Ramesh; Saya Davani; Moise Danielpour; Joshua J Breunig; Keith L Black
Journal:  Adv Drug Deliv Rev       Date:  2021-11-20       Impact factor: 17.873

Review 4.  A Review of Nanotechnology for Treating Dysfunctional Placenta.

Authors:  Huabo Jiang; Li Li; Dan Zhu; Xinyao Zhou; Yongsheng Yu; Qian Zhou; Luming Sun
Journal:  Front Bioeng Biotechnol       Date:  2022-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.